2,096
Views
197
CrossRef citations to date
0
Altmetric
Review

Behcet’s disease: epidemiology, clinical manifestations, and diagnosis

, , , , , , , , , , , & show all
Pages 57-65 | Received 04 Feb 2016, Accepted 21 Jun 2016, Published online: 11 Jul 2016

References

  • Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.
  • Feigenbaum A. Description of Behcet’s syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol. 1956;40:355–357.
  • Shigeta T. Recurrent iritis with hypopion and its pathological findings. Acta Soc Ophthalmol Japan. 1924;28:516.
  • Adamanthiades B. Sur un cas d’iritis a hypopion recidivante. Ann Oculist. 1931;168:271.
  • Behcet H. Uber rezidivierende aphthose, durch ein veirus verusachte geschwure am mund, am auge und an den genitalien. Derm Wschr. 1937;105:1151.
  • Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet’s disease: from east to west. Clin Rheumatol. 2010;29:823–833.
  • Mahr A, Maldini C. Epidemiologie de la Maladie de Behçet. Rev Med Interne. 2014;35:81–89.
  • Cakir N, Dervis E, Benian O, et al. Prevalence of Behcet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol. 2004;22:S53–S55.
  • Azizlerli G, Kose AA, Sarica R, et al. Prevalence of Behcet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803–806.
  • Davatchi F, Sandoughi M, Moghimi N, et al. Epidemiology of rheumatic diseases in Iran from analysis of four COPCORD studies. Int J Rheum Dis. 2015 Dec 1. [Epub ahead of print]. doi:10.1111/1756-185X.12809.
  • Al-Dalaan A, Al-Ballaa S, Al Sukati M, et al. The prevalence of Behcet’s disease in Al Qassim region of Saudi Arabia. In: Hamza M, editor. Behcet’s disease. Tunis (Tunisia): Pub Adhoua; 1997. p. 170–172.
  • Al-Rawi ZS, Neda AH. Prevalence of Behcet’s disease among Iraqis. Adv Exp Med Biol. 2003;528:37–41.
  • Olivieri I, Leccese P, Padula A, et al. High prevalence of Behcet’s disease in southern Italy. Clin Exp Rheumatol. 2013;31(3 Suppl 77):28–31.
  • Krause I, Yankevich A, Fraser A, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26:555–560.
  • Dong Y, Yao K, Wang M. Program and abstract book. 8th APLAR Congress of Rheumatology; 1996 Apr 23–26; Melbourne. p. S14.
  • Nakae K, Masaki F, Hashimoto T, et al. Recent epidemiological features of Behcet’s disease in Japan. In: Wechsler B, Godeau P, editors. Behcet’s Disease. Amsterdam: Excerpta Medica; 1993. p. 145–151.
  • Assaad-Khalil S, Kamel F, Ismail E. Starting a regional registry for patients with Behcet’s disease in North West Nile Delta region in Egypt. In: Hamza M, editor. Behcet’s disease. Tunis (Tunisia): Pub Adhoua; 1997. p. 173–176.
  • Sanchez-Burson J, Grandal Y, Mendoza M, et al. Clinical characteristics, HLA antigen and mortality in Behcet’s syndrome in Spain. In: Olivieri I, Salvarani C, Cantini F, editors. 8th international congress on Behcet’s disease: program and abstracts. Reggio Emilia, Italy. Milan: Prex; 1998. p. 102.
  • Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behcet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58:3951–3959.
  • Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Behcet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61:600–604.
  • Papoutsis NG, Abdel-Naser MB, Altenburg A, et al. Prevalence of Adamantiades-Behcet’s disease in Germany and the municipalityof Berlin: results of a nationwide survey. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S125.
  • Altenburg A, Davatchi F, Sadeghi B, et al. 2014 update of demographic data of Adamantiades-Behçet disease patients in Germany with focus on juvenile vs. adult onset and Turkish vs. German descent. 16th International Conference on Behcet’s Disease; 2014 Sep 18-20; Paris, France. p. P36. Available from: http://www.kobe.fr/behcets/abstracts/abstracts.pdf
  • Mohammad A, Mandl T, Sturfelt G, et al. Incidence, prevalence and clinical characteristics of Behcet’s disease in southern Sweden. Rheumatology(Oxford). 2013;52:304–310.
  • Crespo J, Ribeiro J, Jesus E, et al. Behcet’s disease – particular features at the central zone of Portugal. In: Wechsler B, Godeau P, editors. International Congress Series, 1037. Amsterdam: Excerpta Medica; 1993. p. 207–210.
  • Seaman G, Pearce RA. Behcet’s disease manifestation in a population drawn from the UK Behcet’s syndrome society. In: Hamza M, editor. Behcet’s disease. Tunisia: Pub Adhoua; 1997. p. 196–199.
  • Shahram F, Nadji A, Jamshidi AR, et al. Behcet’s disease in Iran, analysis of 5,059 cases. Arch Iran Med. 2004;7:9–14.
  • Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010;13:367–373.
  • Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J. 1997;38:423–427.
  • Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol. 2003;42:346–351.
  • Zhang Z, Peng J, Hou X, et al. Clinical manifestations of Behcet’s disease in Chinese patients. APLAR J Rheumatol. 2006;9:244–247.
  • Bang D, Lee JH, Lee ES, et al. Epidemiologic and clinical survey of Behcet’s Disease in Korea: the first multicenter study. J Korean Med Sci. 2001;16:615–618.
  • Kim DY, Choi MJ, Cho S, et al. Changing clinical expression of Behçet disease in Korea during three decades (1983-2012); chronological analysis of 3674 hospital-based patients. Br J Dermatol. 2014;170:458–461. doi:10.1111/bjd.12661.
  • Benamour S, Naji T, Echchilali K, et al. Study of 1034 cases of Behcet’s disease. Clin Exp Rheumatol. 2006;24(Suppl 42):S13.
  • Rodríguez-Carballeira M, Alba MA, Solans-Laqué R, et al. Registry of the Spanish network of Behçet’s disease: a descriptive analysis of 496 patients. Clin Exp Rheumatol. 2014;32(4Suppl 84):S33–S39. Epub 2014 Jan 30.
  • Ricart JM, Todolí J, Vilata JJ, et al. Behcet’s disease: study of 74 patients. Med Clin (Barc). 2006;127:496–499.
  • Lennikov A, Alekberova Z, Goloeva R, et al. Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol. 2015;34:321–327. doi:10.1007/s10067-013-2442-9.
  • Sachetto Z 1, Mahayri N, Ferraz RH, et al. Behçet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int. 2012 Jul;32(7):2063–2067. Epub 2011 Apr 11. doi:10.1007/s00296-011-1921-z.
  • Neves FS, Caldas CAM, Lage LV, et al. Faraway from the silk route: demographic and clinical features of Behcet’s disease in 106 Brazilian patients. Clin Rheumatol. 2009;28:543–546.
  • B’chir Hamzaoui S, Harmel A, Bouslama K, et al. Behcet’s disease in Tunisia. Clinical study of 519 cases. Rev Med Interne. 2006;27:742–750.
  • B’chir-Hamzaoui S, Larbi T, Abdallah M, et al. La maladie de Behcet au Maghreb. Étude Behcet Maghreb à propos de 1460 patients. La Revue De Médecine Interne. 2009;30(Suppl 4):S229–S231.
  • Berrah A, Remache A, Ouadahi N, et al. Clinical manifestations of Behcet’s disease: analysis of 58 cases. In: Bang D, Lee E, Lee S, editors. Behcet’s disease. Seoul: Design Mecca Publishing; 2000. p. 77–82.
  • Kaklamani VG, Markomichelakis N, Vaiopoulos G, et al. Clinical features of Adamantiades-Behcet’s disease in Greece. In: Bang D, Lee E, Lee S, editors. Behcet’s disease. Seoul: Design Mecca Publishing; 2000. p. 56–59.
  • Al-Waiz M, Al-Joofy I, Muslih R, et al. General aspects and clinical manifestations of 100 Iraqi patients with Behcet’s disease. Adv Exp Med Biol. 2003;528:91–94.
  • Sharquie KE, Al-Rawi Z, Araji A, et al. Iraqi patients with Behcet’s disease in multidisciplinary clinic. Clin Exp Rheumatol. 2008;26(Suppl. 50):S4.
  • Madanat W, Fayyad F, Verity D, et al. Influence of sex on Behcet’s disease in Jordan. In: Bang D, Lee E, Lee S, editors. Behcet’s disease. Seoul: Design Mecca Publishing; 2000. p. 90–93.
  • Calamia KT, Mazlumzadeh M, Balbanova M, et al. Clinical characteristics of United States patients with Behcet’s disease. In: Bang D, Lee E, Lee S, editors. Behcet’s disease. Seoul: Design Mecca Publishing; 2000. p. 48–51.
  • De Souza-Ramalho P 1, D’Almeida MF, Freitas JP, et al. Behçet’s disease in Portugal. Acta Med Port. 1991;4:79–82.
  • Al-Dalaan AN, Al Balaa SR, El Ramahi K, et al. Behcet’s disease in Saudi Arabia. J Rheumatol. 1994;21:658–661.
  • Hamdan A, Mansour W, Uthman I, et al. Behcet’s disease in Lebanon. Clinical profile, severity and two decade comparison. Clin Rheumatol. 2006;25:364–367.
  • Pande I, Uppal SS, Kailash S, et al. Behcet’s disease in India. A clinical, immunological, immunogenetic and outcome study. Br J Rheumatol. 1995;34:825–830.
  • Arromdee E, Tanakitivirul M. Epidemiology of Behcet’s disease in Thai patients. J Med Assoc Thai. 2006;89(Suppl 5):S182–S186.
  • Tanaseanu S, Pompilian V, Cojocaru I, et al. Clinical particularities in a Romanian series of Behcet’s disease patients. Clin Exp Rheumatol. 2004;22:Suppl S84.
  • Davatchi F, Shahram F, Kumar A, et al. Comparative analysis of Behcet’s disease in the APLAR region. APLAR J Rheumatol. 2004;7:38–43.
  • Shukurova SM. Clinical aspects of Behcet’s disease in patients from Tadjikistan. In: Bang D, Lee E, Lee S, editors. Behcet’s disease. Seoul: Design Mecca Publishing; 2000. p. 83.
  • Valesini G, Pivetti Pezzi P, Catarinelli G, et al. Clinical manifestations of Behcet’s disease in Italy: study of 155 patients at Rome University. In: O’Duffy JD, Kokmen E, editors. Behcet’s disease basic and clinical aspects. New York (NY): Marcel Decker Inc; 1991. p. 279–289.
  • Wang SH, Chu CU, Yang YC, et al. Epidemiological and clinical manifestations of Behcet’s disease in Taiwan. 12th International Conference on Behcet’s disease, Lisbon, Portugal; 2016. Abst B19. Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S1–S45.
  • Davatchi F, Shahram F, Chams-Davatchi C, et al. How to deal with Behcet’s disease in daily practice. Int J Rheum Dis. 2010;13:105–116.
  • Benezra D, Cohen E. Treatment and visual prognosis in Behcet’s disease. Br J Ophthalmol. 1986;70:589–592.
  • Davatchi F, Sadeghi Abdollahi B, Shams H, et al. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet’s disease: longitudinal study of up to 10 years. Int J Rheum Dis. 2014;17:444–452. Epub 2013 Dec 8. doi:10.1111/1756-185X.12248.
  • Fatemi A, Shahram F, Akhlaghi M, et al. Prospective study of articular manifestations in Behcet’s disease: five-year report. Int J Rheum Dis. 2015 Jun 25. [Epub ahead of print]. doi:10.1111/1756-185X.12633.
  • Borhani Haghighi A, Pourmand R, Nikseresht AR. Neuro Behcet’s disease, a review. Neurologist. 2005;11:80–89.
  • Houman MH, Bellakhal S, Ben Salem T, et al. Characteristics of neurological manifestations of Behçet’s disease: a retrospective monocentric study in Tunisia. Clin Neurol Neurosurg. 2013;115:2015–2018.
  • Melikoglu M, Tokarci Z. Is there a relation between clinical disease activity and acute phase response in Behcet’s disease. Int J Dermatol. 2014;53:250–254.
  • Davatchi F, Chams-Davatchi C, Shahram F, et al. Pathergy test in Behcet’s disease: change in incidence over the time. APLAR J Rheumatol. 2007;10:333–335.
  • Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, et al. The saga of diagnostic/classification criteria in Behcet’s disease. Int J Rheum Dis. 2015;18:594–605. Epub 2015 Apr 16. doi:10.1111/1756-185X.12520.
  • International Team for the Revision of the International Criteria for Behcet’s Disease (ITR-ICBD), Davatchi F, Assaad-Khalil S, Calamia KT, et al. The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338–347.
  • International Study Group for Behcet’s Disease. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335:1078–1080.
  • France- Wechsler B, Iran- Davatchi F, Japan- Mizushima Y, et al. Evaluation of Diagnostic (‘Classification’) criteria in Behcet’s disease – toward internationally agreed criteria. Brit J Rheumatol. 1992;31:299–308.
  • Davatchi F, Shahram F, Akbarian M, et al. Accuracy of existing diagnostic criteria for Behcet’s disease. In: Wechsler B, Godeau P, editors. Behcet’s disease. Amsterdam: Excerpta Medica International Congress Series 1037; 1993. p. 225–228.
  • Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, et al. Validation of the revised International Criteria for Behcet’s Disease (ICBD) in Iran. Clin Rheumatol. 2015;34:315–320. Epub 2013 Oct 23, ahead of print. doi:10.1007/s10067-013-2411-3.
  • Davatchi F, Tehrani-Banihashemi A, Jamshidi AR, et al. The prevalence of oral aphthosis in a normal population in Iran: a WHO-ILAR COPCORD study. Arch Iran Med. 2008;11:207–209. doi:08112/AIM.0016.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.